Transcriptional effects of actin-binding compounds: the cytoplasm sets the tone

Cell Mol Life Sci. 2018 Dec;75(24):4539-4555. doi: 10.1007/s00018-018-2919-4. Epub 2018 Sep 11.

Abstract

Actin has emerged as a versatile regulator of gene transcription. Cytoplasmatic actin regulates mechanosensitive-signaling pathways such as MRTF-SRF and Hippo-YAP/TAZ. In the nucleus, both polymerized and monomeric actin directly interfere with transcription-associated molecular machineries. Natural actin-binding compounds are frequently used tools to study actin-related processes in cell biology. However, their influence on transcriptional regulation and intranuclear actin polymerization is poorly understood to date. Here, we analyze the effects of two representative actin-binding compounds, Miuraenamide A (polymerizing properties) and Latrunculin B (depolymerizing properties), on transcriptional regulation in primary cells. We find that actin stabilizing and destabilizing compounds inversely shift nuclear actin levels without a direct influence on polymerization state and intranuclear aspects of transcriptional regulation. Furthermore, we identify Miuraenamide A as a potent inducer of G-actin-dependent SRF target gene expression. In contrast, the F-actin-regulated Hippo-YAP/TAZ axis remains largely unaffected by compound-induced actin aggregation. This is due to the inability of AMOTp130 to bind to the amorphous actin aggregates resulting from treatment with miuraenamide. We conclude that actin-binding compounds predominantly regulate transcription via their influence on cytoplasmatic G-actin levels, while transcriptional processes relying on intranuclear actin polymerization or functional F-actin networks are not targeted by these compounds at tolerable doses.

Keywords: Latrunculin; MRTF-A; Miuraenamide; Nuclear actin; Transcription; YAP.

MeSH terms

  • Actins / drug effects*
  • Actins / metabolism
  • Adaptor Proteins, Signal Transducing / metabolism
  • Animals
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology*
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • Cytoplasm / drug effects
  • Cytoplasm / metabolism
  • Depsipeptides / pharmacology*
  • Gene Expression Regulation / drug effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Mice
  • NIH 3T3 Cells
  • Thiazolidines / pharmacology*
  • Trans-Activators / metabolism
  • Transcription, Genetic / drug effects*

Substances

  • Actins
  • Adaptor Proteins, Signal Transducing
  • Bridged Bicyclo Compounds, Heterocyclic
  • Depsipeptides
  • Thiazolidines
  • Trans-Activators
  • miuraenamide A
  • latrunculin B